Table I.
Comparison of anosmia prevalence in previous pandemicsa
Pandemic | Years | Virus | Variant | Anosmia (%) | Refs for anosmia prevalence |
---|---|---|---|---|---|
Pandemic of 1889 | 1889–1892 | Corona? | <1% | [4] | |
Pandemic of 1918 | 1918–1920 | Influenza | Not common | [3]b | |
SARS | 2002 | SARS-CoV-1 | <0.1% | [5,6] | |
HCoV-NL63 | 2004 | Corona | No reports found | N/A | |
MERS | 2012 | Corona | Not listed | [7] | |
COVID-19 | 2019–2020 | SARS-CoV-2 | D614 | ~10% | [37,38] |
2020–2021 | G614 | 30–50% | [37,38,105] | ||
2021–? | Omicron | ~13% | [105,107,109] |
Abbreviations: D614, original SARS-CoV-2 (Wuhan) strain with an A nucleotide at position 614 of the spike; G614, SARS-CoV-2 variant with a G nucleotide at position 614 of the spike; MERS, Middle East Respiratory Syndrome; N/A, not applicable.
D.A. Pettit, PhD thesis, University of New Hampshire, 1976 (https://scholars.unh.edu/dissertation/1145/).